Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
ADCY10
57%
Adenylate Cyclase Activity
14%
Adenylate Cyclase Inhibitor
14%
Alternative Therapeutics
14%
CD4+
14%
Cell number
14%
Cell-mediated
14%
Cyclic Adenosine Monophosphate (cAMP)
42%
Ear Swelling
14%
Erythema
14%
Gene Expression
42%
Imiquimod
100%
Imiquimod-induced
42%
Inflammation
100%
Interleukin-17 (IL-17)
57%
Keratinocytes
28%
Knock
14%
Mouse Skin
14%
Naïve T Cells
14%
Phosphodiesterase Inhibitors
14%
Psoriasiform Dermatitis
57%
Psoriasis
100%
Psoriasis Pathogenesis
14%
Putative Drug Targets
100%
Skin Diseases
14%
Small Molecules
14%
Soluble Adenylyl Cyclase
100%
T Cell Proliferation
14%
T Helper 17 (Th17)
71%
Th17 Polarization
14%
Therapeutic Efficacy
14%
Therapeutic Target
14%
Topical Application
14%
Topical Therapy
14%
Transcription Factor
14%
Tumor-draining Lymph Nodes
14%
Wild Mice
14%
Pharmacology, Toxicology and Pharmaceutical Science
Adenylate Cyclase
100%
Adenylate Cyclase Inhibitor
14%
Combination Therapy
14%
Cyclic AMP
42%
Diseases
14%
Erythema
14%
Imiquimod
100%
Inflammation
100%
Interleukin 17
14%
Phosphodiesterase Inhibitor
14%
Psoriasis
100%
Transcription Factors
14%
Wild Type Mouse
14%
Immunology and Microbiology
CD4
16%
Cell Count
16%
Dermatitis
66%
Gene Expression
50%
Imiquimod
100%
In Vitro
16%
Interleukin 17
16%
Keratinocyte
33%
Lineages
16%
Lymph Node
16%
Naive T Cell
16%
Secretion (Process)
16%
T Cell Proliferation
16%
Th17 Cell
50%
Transcription Factors
16%
Wild Type Mouse
16%